MedTrace Logo

Protein Intake & Insulin Action

NCT02004002 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2016-10-12

No results posted yet for this study

Summary

The purpose of this proposal is to determine whether dietary protein restriction has beneficial effects on skeletal muscle insulin sensitivity and β-cell function in obese men and women.

Conditions

Interventions

BEHAVIORAL

Weight maintenance with normal protein intake

Control group will consume 1.4 g/kg/d of protein; consistent with the average protein intake in the US population.

BEHAVIORAL

Weight maintenance with protein restriction

Protein restriction group will receive the Institute of Medicine RDA of 0.8 g protein/kg body wt/d.

Sponsors & Collaborators

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Gordon Smith, PhD · Washington University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2016-07-31
Completion
2016-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02004002 on ClinicalTrials.gov